Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany

World Journal of Gastroenterology

Volumn 19, Issue 47, 2013, Pages 9012-9019

  Scherübl, Hans ^a   Streller, Brigitte ^b   Stabenow, Roland ^b   Herbst, Hermann ^c   Höpfner, Michael ^d   Schwertner, Christoph ^a   Steinberg, Joachim ^a   Eick, Jan ^a   Ring, Wanda ^a   Tiwari, Krishna ^a   Zappe, Sören M ^e  

^a VIVANTES KLINIKUM AM URBAN   (Germany)

^b Gemeinsames Krebsregis ter der Länder   (Germany)

^c Brandenburg Klinik   (Germany)

^d MARTIN LUTHER KRANKENHAUS   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endoscopy; Epidemiology; Gastrinoma; German history; Insulinoma; Neuroendocrine; Reunifcation; Second malignancy; Tumor

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; SURVIVAL RATE;

ENDOSCOPY; EPIDEMIOLOGY; GASTRINOMA; GERMAN HISTORY; INSULINOMA; NEUROENDOCRINE; REUNIFICATION; SECOND MALIGNANCY; TUMOR;

FEMALE; GERMANY; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; LIFE TABLES; MALE; NEOPLASMS, SECOND PRIMARY; PANCREATIC NEOPLASMS; PROGNOSIS; REGISTRIES; SEX DISTRIBUTION; SEX FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84890959488     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i47.9012     Document Type: Article

References (34)

1. Berge T., Linell F. Carcinoid tumours. Frequency in a de-fined population during a 12-year period. Acta Pathol Micro-biol Scand A 1976; 84: 322-330 [PMID: 961424 DOI: 10.1111/ j.1699-0463.1976.tb00122.x]
2. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 2005; 19: 753-781 [PMID: 16253899 DOI: 10.1016/j.bpg.2005.06.002]
3. Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G. Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc 2011; 3: 133-139 [PMID: 21860682 DOI: 10.4253/wjge.v3.i7.133]
4. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005; 103: 1587-1595 [PMID: 15742328 DOI: 10.1002/cncr.20939]
5. Doll R, Payne PM, Waterhouse JAH. Cancer incidence in five countries. International Union Against Cancer. Berlin: Springer-Verlag, 1966
6. Eriksson B, Oberg K. Neuroendocrine tumours of the pancreas. Br J Surg 2000; 87: 129-131 [PMID: 10671915 DOI: 10.1046/j.1365-2168.2000.01277.x]
7. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, im-munohistochemical observation and a review of the literature. Eur J Surg Oncol 1997; 23: 36-42 [PMID: 9066745 DOI: 10.1016/S0748-7983(97)80140-0]
8. Modlin IM, Oberg K, Chung DC, Jensen RT, De Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neu-roendocrine tumours. Lancet Oncol 2008; 9: 61-72 [PMID: 18177818 DOI: 10.1016/S1470-2045(07)70410-2]
9. Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG. Epidemiology and survival in patients with carci-noid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001; 12: 1295-1300 [PMID: 11697843 DOI: 10.1016/S0016-5085(08)81267-X]
10. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol 2004; 43: 617-625 [PMID: 15545182 DOI: 10.1080/0284186041 0018575]
11. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M. Guidelines for the management of gastroenteropancreaticneuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specifc NE tumour types. Acta Oncol 2004; 43: 626-636 [PMID: 15545183 DOI: 10.1080/0284 1860410018584]
12. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, De Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394-424 [PMID: 15838182]
13. Tomassetti P, Campana D, Piscitelli L, Casadei R, Nori F, Brocchi E, Santini D, Pezzilli R, Corinaldesi R. Endocrine tumors of the ileum: factors correlated with survival. Neu-roendocrinology 2006; 83: 380-386 [PMID: 17016032 DOI: 10.1159/000096053]
14. Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113: 2655-2664 [PMID: 18853416 DOI: 10.1002/cncr.23883]
15. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959 [PMID: 12569593 DOI: 10.1002/cncr.11105]
16. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072 [PMID: 18565894 DOI: 10.1200/JCO.2007.15.4377]
17. Stang A, Stegmaier C, Eisinger B, Stabenow R, Metz KA, Jöckel KH. Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience. Br J Cancer 1999; 80: 1440-1444 [PMID: 10424748 DOI: 10.1038/ sj.bjc.6690541]
18. Scherübl H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy 2009; 41: 162-165 [PMID: 19214898 DOI: 10.1055/s-0028-1119456]
19. Kaminski M, Polkowski M, Regula J. Prevalence and endo-scopic features of rectal neuroendocrine tumors (carcinoids) among 50148 participants of the Polish colorectal-cancer screening programe. Gut 2007; 56: 310
20. Matsui K, Iwase T, Kitagawa M. Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment. Am J Gastroenterol 1993; 88: 1949-1953 [PMID: 8237948]
21. Shim KN, Yang SK, Myung SJ, Chang HS, Jung SA, Choe JW, Lee YJ, Byeon JS, Lee JH, Jung HY, Hong WS, Kim JH, Min YI, Kim JC, Kim JS. Atypical endoscopic features of rectal carcinoids. Endoscopy 2004; 36: 313-316 [PMID: 15057680 DOI: 10.1055/s-2004-814202]
22. Klöppel G, Scherübl H. Neuroendocrine neoplasms of the appendix and colorectum. Pathologe 2011; 32: 314-320 [PMID: 21655999 DOI: 10.1007/s00292-011-1438-y]
23. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M. Epidemiologi-cal study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 2010; 45: 234-243 [PMID: 20058030 DOI: 10.1007/s00535-009-0194-8]
24. Kvols LK, Brendtro KL. The North American Neuroendo-crine Tumor Society (NANETS) guidelines: mission, goals, and process. Pancreas 2010; 39: 705-706 [PMID: 20664469 DOI: 10.1097/MPA.0b013e3181eb7451]
25. Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöp-pel G. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 2010; 42: 664-671 [PMID: 20669078 DOI: 10.1055/ s-0030-1255564]
26. Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G. Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management. World J Gastrointest En-dosc 2010; 2: 325-334 [PMID: 21160582 DOI: 10.4253/wjge. v2.i10.325]
27. Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenter-opancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendo-crine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 2010; 17: 909-918 [PMID: 20702725 DOI: 10.1677/ERC-10-0152]
28. Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol 2010; 105: 2563-2569 [PMID: 20823835 DOI: 10.1038/ajg.2010.341]
29. Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000; 75: 310-316 [PMID: 11135275 DOI: 10.1002/1096-9098(20001 2)75:4<306]
30. Perez EA, Koniaris LG, Snell SE, Gutierrez JC, Sumner WE, Lee DJ, Hodgson NC, Livingstone AS, Franceschi D. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg 2007; 31: 1022-1030 [PMID: 17429568 DOI: 10.1007/s00268-005-0774-6]
31. Gerstle JT, Kauffman GL, Koltun WA. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 1995; 180: 427-432 [PMID: 7719546]
32. Rehfeld JF. The new biology of gastrointestinal hormones. Physiol Rev 1998; 78: 1087-1108 [PMID: 9790570]
33. Zucker KA, Longo WE, Modlin IM, Bilchik AJ, Adrian TE. Malignant diathesis from jejunal-ileal carcinoids. Am J Gas-troenterol 1989; 84: 182-186 [PMID: 2644819]
34. Zar N, Garmo H, Holmberg L, Hellman P. Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine. Eur J Cancer 2008; 44: 718-725 [PMID: 18207733 DOI: 10.1016/ j.ejca.2007.12.003]